Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqqeq
    Junior Member
    • Nov 2009
    • 3

    #1

    Coverage requirement for denovo sequencing

    Is there any study to explore the relationship between read length, raw read accuracy, coverage, genome size and the resulting number of contigs for denovo assembly? I am particularly interested in human genome. For example, if we have 10k reads, do we need less throughput to achieve the same quality assembly?

    Appreciate someone give me some pointers. Simulation is fine too.
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    A place to start would be Lander-Waterman statistics


    however, these don't incorporate the actual structure of the human genome -- notably the repeats. These will favor long reads even more.

    Comment

    • seqqeq
      Junior Member
      • Nov 2009
      • 3

      #3
      Originally posted by krobison View Post
      A place to start would be Lander-Waterman statistics


      however, these don't incorporate the actual structure of the human genome -- notably the repeats. These will favor long reads even more.
      Thanks for the pointer. Its a very useful set of notes. In the NIH estimate for human genome sequencing cost:

      The following 'sequence coverage' values were used in calculating the cost per genome:

      Sanger-based sequencing (average read length=500-600 bases): 6-fold coverage
      454 sequencing (average read length=300-400 bases): 10-fold coverage
      Illumina and SOLiD sequencing (average read length=50-100 bases): 30-fold coverage

      (http://www.genome.gov/sequencingcosts/)

      They listed different coverage numbers from that estimated from Lander-Waterman statistics. If I use genome size 3Gb, 1 contig, read lengths 600, 400 and 100 bps, the formula gives coverage of 20.2, 18.7 and 18.3. (The numbers above are 30, 10 and 6). Any idea why its way off, esp for Sanger?

      Comment

      • jebowers
        Member
        • Apr 2013
        • 19

        #4
        I would assume the NIH estimates take into account repeats and error rates as well as sequencing biases.

        Different sequencing technologies favor different GC% sequences, and to get the 99% coverage some technologies must sequence more to get the needed coverage of GC% extremes.

        Also repeats complicate matters, as short sequences containing repeats can not be effectively anchored, requiring higher coverage.

        Finally error rates result in some loss of coverage, again depending on the tech used.

        So in summary, yes a formula would be great, but guidelines based on experimental results are probably going to be more accurate as several different factors besides read length strongly impact the results.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-11-2026, 10:35 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...